Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Colorectal cancer
ADR ID BADD_A05905
ADR Hierarchy
07      Gastrointestinal disorders
07.21      Malignant and unspecified neoplasms gastrointestinal NEC
07.21.01      Malignant intestinal neoplasms
07.21.01.002      Colorectal cancer
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.13      Gastrointestinal neoplasms malignant and unspecified
16.13.01      Colorectal neoplasms malignant
16.13.01.002      Colorectal cancer
Description Tumors or cancer of the COLON or the RECTUM or both. Risk factors for colorectal cancer include chronic ULCERATIVE COLITIS; FAMILIAL POLYPOSIS COLI; exposure to ASBESTOS; and irradiation of the CERVIX UTERI. [MeSH]
MedDRA Code 10061451
MeSH ID D015179
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
Colorectal cancer NOS | Colorectal carcinoma | Colorectal cancer | Mismatch repair deficient colorectal cancer | Microsatellite instability-high colorectal cancer | Colorectal Neoplasms | Neoplasms, Colorectal | Colorectal Neoplasm | Neoplasm, Colorectal | Colorectal Tumors | Colorectal Tumor | Tumor, Colorectal | Tumors, Colorectal | Colorectal Carcinoma | Carcinoma, Colorectal | Carcinomas, Colorectal | Colorectal Carcinomas | Colorectal Cancer | Cancer, Colorectal | Cancers, Colorectal | Colorectal Cancers
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00349Capecitabine--
BADD_D00567Dabrafenib mesylate--
BADD_D00869Famotidine0.000318%
BADD_D01195Irinotecan0.000302%
BADD_D01817Pramipexole--
BADD_D01818Pramipexole dihydrochloride--
BADD_D01822Prasugrel--
BADD_D01913Ranitidine0.029240%
BADD_D01922Regorafenib0.010465%
BADD_D02236Tofacitinib--
BADD_D02237Tofacitinib citrate--
BADD_D02252Tositumomab--
BADD_D02331Valsartan0.001905%
BADD_D02596Sotorasib0.000112%
The 1th Page    1    Total 1 Pages